Evaluation of the Artus® CMV PCR Test
NCT01034709 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 111
Last updated 2014-08-20
Summary
Subjects with symptomatic CMV infection, who are enrolled in this clinical study, will be monitored during antiviral therapy.
Conditions
- Cytomegalovirus Infections
Sponsors & Collaborators
-
QIAGEN Gaithersburg, Inc
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-12-31
- Primary Completion
- 2013-09-30
- Completion
- 2014-06-30
Countries
- United States
Study Locations
More Related Trials
-
Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis
NCT00002070 ·Status: COMPLETED ·Phase: PHASE3
-
A Long-Term Extension Study to Evaluate the Immunogenicity and Safety of Cytomegalovirus (CMV) mRNA-1647 Vaccine
NCT04975893 ·Status: COMPLETED ·Phase: PHASE2
-
A Study in Adolescent Females to Explore Cytomegalovirus Infection
NCT01691820 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes
NCT00002377 ·Status: COMPLETED ·Phase: PHASE3
-
Cytomegalovirus (CMV) Vaccines: Reinfection and Antigenic Variation
NCT03443791 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Long-term Persistence of GlaxoSmithKline (GSK) Biologicals' Candidate Cytomegalovirus (CMV) Vaccine
NCT01357915 ·Status: COMPLETED ·Phase: NA
-
Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS
NCT00001061 ·Status: COMPLETED ·Phase: PHASE2
-
Detection of Cytomegalovirus Virus in Neonates
NCT03251261 ·Status: COMPLETED
-
A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency Virus
NCT00002095 ·Status: COMPLETED ·Phase: NA
-
Clinical and Immunological Features of the CMV Infection Atypical Course in Immunocompetent Individuals
NCT04392297 ·Status: COMPLETED
-
V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002)
NCT03486834 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-Finding Trial to Evaluate the Safety and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 in Healthy Adults
NCT04232280 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Safety and Immunogenicity of the GSK Bio CMV Vaccine in CMV-seronegative Healthy Male Adult Subjects
NCT00435396 ·Status: COMPLETED ·Phase: PHASE1
-
Kinetics of Response of Cytomegalovirus With Ganciclovir Treatment Using Quantitative Real-Time PCR
NCT00004573 ·Status: UNKNOWN ·Phase: NA
-
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
NCT01376778 ·Status: COMPLETED ·Phase: PHASE3
-
Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV
NCT00006145 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis
NCT00002169 ·Status: COMPLETED ·Phase: PHASE2
-
Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients With Acute Respiratory Failure and Sepsis
NCT04706507 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes
NCT00001062 ·Status: COMPLETED ·Phase: PHASE1
-
CMV-specific Donor-derived T Lymphocytes for the Treatment of Recalcitrant CMV Infection in a Patient With Primary Immunodeficiency
NCT07015801 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Cell-Mediated Immunity Based Primary Prophylaxis for CMV Infection in Organ Transplant Recipients
NCT02784756 ·Status: COMPLETED ·Phase: NA
-
A Study of AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) Infection
NCT00000995 ·Status: COMPLETED ·Phase: NA
-
A Study on Cytomegalovirus (CMV) Infection Outcomes Among Hematopoietic Stem Cell Transplant (HSCT) Participants in Europe and Canada
NCT05571137 ·Status: COMPLETED
-
Trial to Evaluate Safety and Immunogenicity of a Vaccine Against HCMV
NCT02798692 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir
NCT00000970 ·Status: COMPLETED ·Phase: PHASE1